Group 1 - The Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, lead plaintiff deadline for a class action lawsuit [1][2] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - The lawsuit alleges that Centene's management provided misleading information regarding the company's expected revenue guidance and adjusted diluted earnings per share for the 2025 fiscal year, while concealing adverse facts about enrollment and morbidity rates [4] Group 2 - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] - The lawsuit claims that when the true state of Centene's enrollment and morbidity rates became known, investors suffered damages [4]

Core Viewpoint - A lawsuit has been filed against Centene Corporation and its senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Company Overview - Centene Corporation is a healthcare company that provides services to consumers enrolled in government-sponsored healthcare programs such as Medicaid and Medicare, as well as those purchasing insurance under the Affordable Care Act [3]. Financial Guidance and Performance - On December 12, 2024, Centene announced financial guidance for fiscal year 2025, claiming stability in earnings despite challenges [4]. - The company increased its 2025 guidance on February 4, 2025, citing enrollment overperformance, and again on April 25, 2025, due to strong growth in enrollment and retention [4]. - However, the actual market conditions showed lower than expected enrollment growth and increased morbidity rates in the majority of the states Centene serves [4]. Stock Market Reaction - On July 1, 2025, Centene withdrew its previous guidance after an independent actuarial report revealed lower than expected market growth and higher morbidity rates, leading to a significant stock price drop of $22.87 per share, or over 40%, from $56.65 to $33.78 [5].

Core Viewpoint - Centene Corporation is facing a class action securities lawsuit due to alleged securities fraud that affected investors between December 12, 2024, and June 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Centene's management provided overly positive statements while concealing material adverse facts regarding the company's enrollment and morbidity rates [2]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, leading to a revised guidance of approximately $1.8 billion and an adjusted diluted EPS of $2.75 [2]. - Following this announcement, Centene's stock price plummeted from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025, marking a decline of 40.4% [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until September 8, 2025, to request the Court to appoint them as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - A lawsuit has been filed against Centene Corporation and its senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Company Overview - Centene Corporation is a healthcare company that provides services to consumers enrolled in government-sponsored healthcare programs such as Medicaid and Medicare, as well as those purchasing insurance under the Affordable Care Act [3]. Financial Guidance and Performance - On December 12, 2024, Centene announced financial guidance for fiscal year 2025, claiming stability in earnings despite challenges [4]. - The company increased its 2025 guidance on February 4, 2025, citing enrollment overperformance, and again on April 25, 2025, due to strong growth in enrollment and retention [4]. - However, the actual market conditions showed lower than expected enrollment growth and increased morbidity rates in the majority of the states Centene serves [4]. Stock Market Reaction - On July 1, 2025, Centene withdrew its previous guidance after an independent actuarial report revealed lower than expected market growth and higher morbidity rates, leading to a significant stock price drop of $22.87 per share, or over 40%, from $56.65 to $33.78 [5].

Core Insights - The partnership between Meridian Health Plan of Michigan and the Centene Foundation aims to enhance access to fresh food and improve health outcomes in rural southwest Michigan through a $1 million grant to the Food Bank Council of Michigan [1][8] - The initiative focuses on addressing food insecurity, which is linked to diet-sensitive chronic diseases, by implementing a two-phased program that includes upgrading food pantries and establishing a fresh food pharmacy [2][5] Phase One Summary - Phase One will upgrade two existing food pantries to become Nourish MI Pantries, which will provide fresh, nutritious food and support health and equity partnerships [2][3] - The upgraded pantries will implement food as medicine interventions and receive technological support for future In Lieu of Services (ILOS) implementation [4] - The initiative aims to strengthen local food access and build capacity for ILOS operations for participating Medicaid health plans [4] Phase Two Summary - Phase Two, starting in 2026, will designate and upgrade five additional Nourish MI Pantries and fund the Fresh Food Pharmacy program at Grace Health [5] - The Fresh Food Pharmacy will assist eligible patients with diet-sensitive chronic conditions in accessing nutritious food and health education [5] Context of Food Insecurity - Over 1.4 million people in Michigan face food insecurity, with more than 378,000 being children, particularly affecting rural communities with limited access to grocery stores [6] - The partnership aims to address the root causes of health disparities and improve overall health outcomes in these communities [2][8] Organizational Background - Meridian Health Plan of Michigan provides managed care services primarily through Medicaid and is part of Centene Corporation [9] - The Centene Foundation focuses on investing in economically challenged communities and improving health equity [10] - The Food Bank Council of Michigan leads efforts to end hunger in the state by advocating for policies and providing resources to food banks [11]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Centene Corporation due to misleading statements regarding the company's enrollment and morbidity rates, which led to significant financial losses for investors [3][5]. Group 1: Legal Actions and Investor Information - Investors who suffered losses exceeding $75,000 in Centene between December 12, 2024, and June 30, 2025, are encouraged to contact Faruqi & Faruqi for legal options [1]. - There is a deadline of September 8, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Centene [3]. - The lead plaintiff is defined as the investor with the largest financial interest who directs the litigation on behalf of the class [7]. Group 2: Company Performance and Stock Impact - Centene's stock price fell dramatically from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025, marking a decline of 40.4% following the withdrawal of 2025 guidance [6]. - The company revised its guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 after a preliminary analysis indicated lower-than-expected market growth across 22 states, which represents 72% of its marketplace membership [5]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4].

"This mobile health clinic will be a lifeline for many students and families who might otherwise struggle to access care," said Scott Sivik, plan president and chief executive officer of 'Ohana Health Plan. "It represents a powerful step forward in ensuring that every child on Hawai'i Island has access to the care they need to thrive. We're proud to support this partnership that brings healthcare directly to our keiki." For more information about Hawai'i Island Community Health Center, School-Based Health C ...

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of providing misleading statements regarding its enrollment and morbidity rates, which led to a significant decline in its stock price after the company withdrew its 2025 guidance [3][4]. Summary by Relevant Sections Allegations - The complaint alleges that Centene's management made overwhelmingly positive statements to investors while concealing material adverse facts about the company's true enrollment and morbidity rates [3]. - On July 1, 2025, Centene issued a press release withdrawing its 2025 guidance, which raised investor concerns about the accuracy of previous public statements [3]. - The company's preliminary analysis indicated that its overall market growth across 22 states, representing 72% of its marketplace membership, was lower than expected, leading to a reduction in guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 [3]. Stock Price Impact - Following the announcement on July 1, 2025, Centene's stock price plummeted from a closing price of $56.65 per share to $33.78 per share on July 2, 2025, marking a decline of 40.4% [3]. Class Action Details - The class period for the lawsuit is defined as December 12, 2024, to June 30, 2025, and shareholders are encouraged to register for participation [3][4]. - The deadline for shareholders to seek lead plaintiff status is September 8, 2025, and there is no cost or obligation to participate in the case [4]. Firm's Commitment - The Gross Law Firm, which is handling the case, emphasizes its mission to protect investors' rights and ensure companies adhere to responsible business practices [5].

Core Insights - The partnership between Peach State Health Plan (PSHP) and Barrow County Schools aims to support holistic student development by addressing health, education, and access needs in the community [1][5] - The Back-to-BOLD event on July 25, 2025, attracted thousands of attendees and served as a unifying moment for the community following a tragic school shooting [1][4] Group 1: Event Highlights - The collaboration included the Centene Foundation and Shoes That Fit, which donated 1,000 pairs of new shoes to students, ensuring they have the necessary resources to start school confidently [2][3] - The Centene Vision Van provided free eye exams and prescription glasses, contributing to the event's positive impact on families [4] Group 2: Community Impact - Dr. Dallas LeDuff, Superintendent of Barrow County Schools, expressed gratitude for the community's support, highlighting the importance of health screenings, immunizations, school supplies, and other resources for families [3] - Clyde A. White, President and CEO of PSHP, emphasized the significance of strong partnerships in fostering community well-being and long-term success for students [5] Group 3: Organizational Background - Peach State Health Plan serves the Medicaid and PeachCare for Kids® populations in Georgia and focuses on under-insured and uninsured individuals through its Ambetter plan [6] - Barrow County School System serves nearly 15,500 students and is the 24th largest school system in Georgia [7] - The Centene Foundation is dedicated to improving health equity and addressing social drivers of health in economically challenged communities [8] - Shoes That Fit is a nonprofit organization that provides new athletic shoes to children in need, having delivered shoes to over 180,000 children across the U.S. last year [9]

Core Insights - Health Net, a subsidiary of Centene Corporation, has awarded $295,000 in grants to organizations aimed at enhancing the quality of life for older adults in California [1][2] - The funding is part of Health Net's broader commitment to community support, having invested over $158 million from 2017 to 2024 in community-based organizations [3] Grant Recipients and Initiatives - A Senior Connection will use the grant to hire personnel for the rollout of the state's Community Supports benefit [6] - NewGen Administrative Services will enhance patient comfort by adding bedside dialysis units, reducing complications from travel to off-site centers [6] - ONEgeneration will expand mental and behavioral health services for older adults, ensuring access to necessary resources [6] - St. Barnabas Senior Services will upgrade kitchen infrastructure to provide healthy, culturally-centered meals for older adults [6] - WISE & Healthy Aging aims to improve collaboration between Skilled Nursing Facility representatives and emergency services to reduce unnecessary 911 calls [6] Company Overview - Health Net has been operating in California for over 45 years, providing health plans for individuals, families, and those eligible for Medi-Cal or Medicare [5] - The company serves more than three million members with a network of over 117,000 providers [5][7] - Centene Corporation, the parent company, is committed to transforming community health through various managed healthcare products and services [7]